If your institution subscribes to this resource, and you don't have an Access Profile, please contact your library's reference desk for information on how to gain access to this resource from off-campus.
Olumiant192
Janus kinase 1 and 2 inhibitor
Rheumatoid arthritis
Ruxolitinib, tofacitinib
Chapter 67. Pathway-Targeted Therapies: Monoclonal Antibodies, Protein Kinase Inhibitors, and Various Small Molecules >Inhibitors of JAK1 and JAK2
eChapter 2018: The Goodman & Gilman Year in Review New and Noteworthy FDA Approvals